Fed. Circ. Says On-Sale Bar May Invalidate Angiomax Patent
The Federal Circuit on Tuesday affirmed a district court's finding that Hospira doesn't infringe two blood thinner patents belonging to The Medicines Co., but remanded the question of whether The Medicines...To view the full article, register now.
Already a subscriber? Click here to view full article